An Atypical Presentation of Liver Enzyme Elevation Resulting from Bosentan Use
Hepatocellular enzyme elevation is a known side effect of both bosentan and atorvastatin. However, a rise in liver enzyme level not characteristic of either agent individually may represent a reaction to their combination or an atypical reaction to bosentan alone.
Saved in:
| Main Authors: | Kimberley Mulchey, Zoheir Bshouty |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2009-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/2009/958617 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vascular Compromise and Hemodynamics in Pulmonary Arterial Hypertension: Model Predictions
by: Zoheir Bshouty
Published: (2012-01-01) -
THE RESULTS OF LONG-TERM PAH-SPECIFIC MONOTHERAPY WITH BOSENTAN IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSION
by: V. M. Paramonov, et al.
Published: (2016-06-01) -
Effect of bosentan therapy in persistent pulmonary hypertension of the newborn
by: Gunlawadee Maneenil, et al.
Published: (2018-02-01) -
ST Elevation in aVR: An Atypical Presentation of Pulmonary Embolism
by: Bernard R. Francis, et al.
Published: (2025-08-01) -
Pulmonary Arterial Hypertension Specific Therapy in Patients with Combined Post- and Precapillary Pulmonary Hypertension
by: Hassan Alfraidi, et al.
Published: (2018-01-01)